The contribution in AD pathogenesis from APOE involves not only Aβ aggregation and its clearance, but also tau-mediated neurodegeneration [24], microglia impairment [25,26], astrocyte reactivity [27], and blood–brain barrier disruption [28,29]. This evidence concerns the gene MAPT and Alzheimer disease.